Spots Global Cancer Trial Database for male breast cancer
Every month we try and update this database with for male breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy | NCT01153672 | Male Breast Can... Recurrent Breas... Stage IV Breast... | vorinostat laboratory biom... biopsy F-18 16 alpha-f... positron emissi... anastrozole letrozole exemestane gene expression... | 18 Years - | University of Washington | |
| Chemotherapy in Treating Patients With Breast Cancer | NCT00012129 | Breast Cancer | liposomal annam... | 18 Years - 120 Years | NYU Langone Health | |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | NCT00471432 | Bladder Cancer Breast Cancer Kidney Cancer Lung Cancer Ovarian Cancer Prostate Cancer Unspecified Adu... | custirsen sodiu... docetaxel pharmacological... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | NCT00007904 | Breast Cancer | filgrastim cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | NCT01100489 | Ductal Breast C... Estrogen Recept... Estrogen Recept... HER2-negative B... HER2-positive B... Invasive Ductal... Invasive Lobula... Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Progesterone Re... Stage I Breast ... Stage II Breast... Tubular Ductal ... | external beam r... questionnaire a... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) | NCT02580448 | Cancer of the B... Breast Cancer Advanced Breast... Metastatic Brea... Male Breast Can... Triple Negative... ER+ Breast Canc... | Seviteronel | 18 Years - | Innocrin Pharmaceutical | |
| Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | NCT00020176 | Breast Cancer | filgrastim therapeutic all... cyclophosphamid... cyclosporine fludarabine pho... peripheral bloo... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu | NCT00085020 | Breast Cancer | trastuzumab lapatinib ditos... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer | NCT00005822 | Breast Cancer | doxorubicin hyd... semaxanib conventional su... radiation thera... tamoxifen | 18 Years - | Case Comprehensive Cancer Center | |
| Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer | NCT01706432 | Central Nervous... Invasive Ductal... Invasive Ductal... Invasive Lobula... Invasive Lobula... Liver Metastase... Lobular Breast ... Lung Metastases Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Recurrent Breas... Stage IV Breast... Tubular Ductal ... Tumors Metastat... | hyperfractionat... laboratory biom... stereotactic ra... | 18 Years - | University of Chicago | |
| Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer | NCT00107510 | Breast Cancer | pegfilgrastim carboplatin docetaxel conventional su... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel | NCT01050075 | Breast Cancer Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | acupuncture the... questionnaire a... management of t... | 18 Years - | City of Hope Medical Center | |
| Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | NCT02013492 | Male Breast Can... Recurrent Melan... Stage IV Breast... Stage IV Melano... Stage IV Ovaria... Stage IV Ovaria... Unspecified Adu... Hepatocellular ... | propranolol hyd... Correlative Stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer | NCT00003135 | Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer | fluorouracil pegylated lipos... hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom | NCT00757211 | Breast Cancer | polymorphism an... laboratory biom... questionnaire a... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Testosterone & Tamoxifen Trial | NCT05156606 | Male Breast Can... | AndroGel | 18 Years - | University Medical Center Groningen | |
| Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer | NCT00898781 | Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc... | - | Mayo Clinic | ||
| Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer | NCT00376805 | Breast Cancer | Fludarabine Cyclophosphamid... Total body irra... Natural killer ... Interleukin-2 | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer | NCT00362973 | Breast Cancer | laboratory biom... needle biopsy positron emissi... radionuclide im... fludeoxyglucose... | 18 Years - 120 Years | University of Washington | |
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | NCT00301925 | Breast Cancer | pegfilgrastim capecitabine cyclophosphamid... epirubicin hydr... fluorouracil methotrexate adjuvant therap... | 18 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer | NCT00054275 | Breast Cancer | docetaxel erlotinib hydro... | 18 Years - | Case Comprehensive Cancer Center | |
| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | NCT01869764 | Ductal Breast C... Lobular Breast ... Male Breast Can... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | omega-3 fatty a... placebo laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer | NCT00054145 | Breast Cancer | perifosine | 18 Years - | University Health Network, Toronto | |
| Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery | NCT01705340 | Adenocarcinoma ... HER2-positive B... Male Breast Can... Recurrent Breas... Recurrent Esoph... Recurrent Gastr... Stage IIIC Brea... Stage IIIC Esop... Stage IIIC Gast... Stage IV Breast... Stage IV Esopha... Stage IV Gastri... | Akt inhibitor M... trastuzumab lapatinib ditos... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer | NCT00424164 | Breast Cancer | lapatinib ditos... tamoxifen citra... pharmacological... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | NCT00379509 | Breast Cancer | lapatinib ditos... TdT-mediated dU... gene expression... microarray anal... immunohistochem... biopsy radiation thera... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer | NCT01938833 | HER2-negative B... Inflammatory Br... Male Breast Can... Recurrent Breas... Stage IV Breast... | Romidepsin Abraxane | 18 Years - | Thomas Jefferson University | |
| 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer | NCT00095888 | Male Breast Can... Recurrent Breas... Stage IV Breast... | triapine gemcitabine hyd... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | NCT00834678 | Breast Cancer | bendamustine erlotinib Maintenance erl... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases | NCT01939483 | Central Nervous... Male Breast Can... Recurrent Breas... Stage IV Breast... | irinotecan hydr... laboratory biom... | 18 Years - | University of California, Irvine | |
| Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer | NCT00086957 | Breast Cancer | trastuzumab docetaxel gefitinib | 18 Years - | City of Hope Medical Center | |
| Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | NCT02060253 | HER2-positive B... Male Breast Can... Recurrent Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | ganetespib paclitaxel trastuzumab pertuzumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer | NCT00898781 | Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc... | - | Mayo Clinic | ||
| Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases | NCT00617539 | Breast Cancer Metastatic Canc... | irinotecan hydr... temozolomide | 18 Years - 120 Years | University of California, San Francisco | |
| Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer | NCT00044993 | Breast Cancer | Ad5CMV-p53 gene docetaxel doxorubicin hyd... conventional su... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane | NCT00059852 | Breast Cancer | erlotinib hydro... gemcitabine hyd... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer | NCT00316875 | Breast Cancer | lapatinib ditos... Doxil | 18 Years - | Northwestern University | |
| Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | NCT00028990 | Breast Cancer | bevacizumab Paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer | NCT00326820 | Breast Cancer Hypercalcemia o... Metastatic Canc... | ibandronate sod... zoledronic acid Zolendronic Aci... | 18 Years - | Wales Cancer Trials Unit | |
| Study of Barriers to Beginning and Finishing Treatment for Patients With Breast Cancer | NCT00937989 | Breast Cancer | educational int... informational i... medical chart r... questionnaire a... study of socioe... quality-of-life... | 50 Years - | City of Hope Medical Center | |
| Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer | NCT00245050 | Breast Cancer Drug/Agent Toxi... Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | pyridoxine hydr... Placebo doxorubicin HCL... | - | Case Comprehensive Cancer Center | |
| Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer | NCT01086605 | Breast Cancer | pixantrone dima... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer | NCT01084057 | Male Breast Can... Recurrent Breas... Stage IV Breast... | vorinostat ixabepilone laboratory biom... pharmacological... | 18 Years - | City of Hope Medical Center | |
| Radiation Therapy in Treating Patients With Recurrent Breast Cancer | NCT00945061 | Breast Cancer | intracavitary b... intraoperative ... | 18 Years - | Case Comprehensive Cancer Center | |
| Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome | NCT00938756 | Brain and Centr... Breast Cancer Metastatic Canc... | diagnostic labo... immunoenzyme te... magnetic resona... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy | NCT00722072 | Breast Cancer | fulvestrant sorafenib tosyl... | 18 Years - 120 Years | OHSU Knight Cancer Institute | |
| Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab | NCT00301899 | Breast Cancer | pertuzumab trastuzumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| PET Scans in Patients With Locally Advanced Breast Cancer | NCT00109785 | Breast Cancer | positron emissi... fludeoxyglucose... iodine I 124 io... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer | NCT00045188 | Male Breast Can... Recurrent Breas... Stage IV Breast... | imatinib mesyla... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer | NCT00897702 | Breast Cancer | Blood draw immunoenzyme te... biopsy histopathologic... | - | Memorial Sloan Kettering Cancer Center | |
| Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients | NCT00820547 | Breast Cancer | bevacizumab cyclophosphamid... docetaxel epirubicin hydr... fluorouracil | 18 Years - | UNICANCER | |
| Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery | NCT00562718 | Breast Cancer | capecitabine adjuvant therap... radiation thera... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00089362 | Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas... | alvespimycin hy... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | NCT01674140 | Breast Cancer | anastrozole everolimus exemestane goserelin aceta... letrozole leuprolide acet... tamoxifen citra... placebo | 18 Years - | SWOG Cancer Research Network | |
| Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer | NCT01042535 | Male Breast Can... Recurrent Breas... Stage IV Breast... Unspecified Adu... | adenovirus-p53 ... 1-methyl-d-tryp... Laboratory biom... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer | NCT00045097 | Breast Cancer | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer | NCT00005807 | Breast Cancer Ovarian Cancer Unspecified Adu... | BMS-247550 | 18 Years - 120 Years | Albert Einstein College of Medicine | |
| Testosterone & Tamoxifen Trial | NCT05156606 | Male Breast Can... | AndroGel | 18 Years - | University Medical Center Groningen | |
| Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | NCT00176488 | Breast Cancer | epirubicin vinorelbine | 21 Years - 120 Years | Rutgers, The State University of New Jersey | |
| Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ | NCT00438659 | Breast Cancer Dermatologic Co... Radiation Toxic... Skin Reactions ... | mometasone furo... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | NCT00007904 | Breast Cancer | filgrastim cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters | NCT00445562 | Breast Cancer | biologic sample... informational i... | 18 Years - | National Cancer Institute (NCI) | |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | NCT00433407 | Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... | trastuzumab | - | Jonsson Comprehensive Cancer Center | |
| Self-Care for Lymphedema in Patients With Breast Cancer | NCT00670644 | Breast Cancer | questionnaire a... survey administ... quality-of-life... | 18 Years - 120 Years | Vanderbilt University | |
| Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients | NCT01638247 | Male Breast Can... | Tamoxifen Tamoxifen and G... Exemestane and ... | 18 Years - 85 Years | German Breast Group | |
| Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer | NCT00470249 | Breast Cancer | Carboplatin Gemcitabine Hyd... | 18 Years - 120 Years | University of Southampton | |
| Phase II Bevacizumab + Tax In Advanced Breast Cancer | NCT00027885 | Breast Cancer | bevacizumab cyclophosphamid... docetaxel doxorubicin hyd... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer | NCT00295893 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... Trastuzumab Carboplatin Paclitaxel | 18 Years - 120 Years | City of Hope Medical Center | |
| Decitabine in Treating Patients With Advanced Solid Tumors | NCT00030615 | Male Breast Can... Recurrent Bladd... Recurrent Breas... Recurrent Melan... Stage III Melan... Stage IV Bladde... Stage IV Breast... Stage IV Melano... Unspecified Adu... | decitabine pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters | NCT00445562 | Breast Cancer | biologic sample... informational i... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer | NCT00616122 | Breast Cancer | cyclophosphamid... methotrexate sunitinib malat... laboratory biom... | 18 Years - 120 Years | University of California, San Francisco | |
| Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | NCT00093808 | Breast Cancer | trastuzumab capecitabine vinorelbine tar... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | NCT00301925 | Breast Cancer | pegfilgrastim capecitabine cyclophosphamid... epirubicin hydr... fluorouracil methotrexate adjuvant therap... | 18 Years - 120 Years | Institute of Cancer Research, United Kingdom | |
| PET Scans in Patients With Locally Advanced Breast Cancer | NCT00109785 | Breast Cancer | positron emissi... fludeoxyglucose... iodine I 124 io... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel | NCT01050075 | Breast Cancer Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | acupuncture the... questionnaire a... management of t... | 18 Years - | City of Hope Medical Center | |
| Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer | NCT00898781 | Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc... | - | Mayo Clinic | ||
| Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer | NCT00574366 | Breast Cancer | erlotinib RAD001 | 18 Years - | Vanderbilt-Ingram Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
